Interestingly, in previous work with PBMCs, the expression of NFE2L2 had no changes in relation to controls, but ALS patients were 10 years older than in our study [13], which could indicate a time-dependent NFE2L2 expression. This evidence concerns the gene NFE2L2 and amyotrophic lateral sclerosis.